Post‐surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID‐19.
There are increasing reports of autoimmune and dermatologic sequelae of COVID‐19. We describe an otherwise healthy patient with recent history of serious COVID‐19 infection who developed post‐surgical pyoderma gangrenosum following bilateral reduction mammoplasty and was successfully treated with in...
| Published in: | Breast Journal Vol. 27; no. 8; pp. 671 - 675 |
|---|---|
| Main Authors: | , , |
| Format: | case study pictorial tables/charts Journal Article |
| Published: |
Wiley-Blackwell
Aug2021
|
| Online Access: | View this record in EBSCOhost |
| Summary: | There are increasing reports of autoimmune and dermatologic sequelae of COVID‐19. We describe an otherwise healthy patient with recent history of serious COVID‐19 infection who developed post‐surgical pyoderma gangrenosum following bilateral reduction mammoplasty and was successfully treated with infliximab, mycophenolic acid, and corticosteroids. We present this case to highlight the lingering systemic proinflammatory effects of COVID‐19 infection that may increase the risk of rare autoimmune complications of surgery. As a complete understanding of the long‐term effects of COVID‐19 is poorly understood, patients with a history of COVID‐19 infection should be appropriately counseled to these possible risks when discussing surgery. |
|---|